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Background: Several factors including neuroinflammation and oxidative stress formation contribute to the 
progression and development of cognitive impairment. Lipopolysaccharide (LPS) injection has been used as 
non-transgenic mouse models for Alzheimer’s diseases (AD). Plant medicine has been proposed to be the 
prospect in treatment/ management of neurodegenerative disease.  
Aim: The present study sought to evaluate the effect of three medicinal plants (Bacopa floribunda (R.Br)Wettst, 
Scoparia dulcis L and Cordia millenii Bak.) locally used for memory enhancement on neuronal histology and 
antioxidant status against Lipopolysaccharide induced neuronal damage in mice. 
Methods: Forty-nine (49) BALB/c male mice were randomly grouped into seven (7) groups of 7 mice each. All 
animals except in group I control (vehicle), were injected intraperitoneally (I.P.) with LPS (250 μg/kg) once, 
after oral pre-treatment with plant extracts and control drugs for 7 days. Group II  (untreated) received LPS only 
(250 μg/kg) , group III received LPS + Sulindac Sulfide (SS, 4 mg/kg), group IV received LPS + Donepezil 
(DPZ, 1 mg/kg) group V, VI, and VII received LPS + 200 mg/kg of plant extracts [Scoparia dulcis (SD), 
Bacopa floribunda (BF), and Cordia millenii (CM)] respectively. After the experiment, histological analysis of 
the hippocampus from the whole brain was carried out while the other brain tissues comprising frontal cortex 
and cerebellum were used for determination of biomarkers of antioxidant status such as catalase (CAT); 
superoxide dismutase (SOD); malondialdehyde (MDA) and reduced glutathione (GSH).  
Results: Oral administration of LPS induced neuronal damage through cell death as evidenced by the 
histological analysis and altered brain antioxidant status in mice. However, the plant extracts were able to 
prevent such neuronal alterations and restored the antioxidant status when compared to the LPS induced 
neuronal damage in mice. 
Conclusion: LPS induced neuroinflammation was prevented by the extracts of; B. floribunda, S. dulcis and C. 
millenni. Neural damage was also prevented by the extracts. This activity could be attributed to their antioxidant 
potential as evidenced from their inhibitory effect on MDA and increased CAT activity and GSH. Nevertheless, 
other possible mechanisms of action against neuronal damage need to be assessed to further justify their use 
traditionally in the treatment/management of neurodegenerative diseases.  
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INTRODUCTION 
 
Neurodegenerative disorders such as Alzheimer’s 
disease (AD) and Parkinson disease (PD) are common among the  
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elderly ones and characterized by progressive cognitive deficits 
and behavioral disturbances (Norton et al., 2014). Several complex 
pathogenic pathways have been found to be involved in the disease 
development and progression, which include amyloid beta 
accumulation, neurofibrillary tangle formation (Terry and Masliah, 
1991), cholinergic deficit and oxidative stress (Perry et al., 2002, 
Frank and Gupta, 2005; Dastmalchi et al., 2007; Norton et al., 
2014).  
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The contribution of the inflammatory component of 
diverse disorders to disease progression has led to novel attempts 
aimed at discovering ways to attenuate inflammation 
therapeutically (Nathan, 2002). Neuroinflammation and oxidative 
stress play crucial role in the pathogenesis of chronic 
neurodegenerative diseases such as AD. However, aberrant 
activation due to diverse stimulus is neurotoxic and often 
detrimental leading to neurodegeneration (Streit et al., 2004). 
Previous studies have implicated oxidative stress to play a crucial 
role in neurodegenerative diseases such as AD via lipid 
peroxidation of cell membrane of the neurons (Pratico and Delanty 
2000; Oboh et al., 2012).  Excessive oxidative stress is thought to 
have an important role in the pathogenesis of autoimmune diseases 
by enhancing the inflammation, inducing apoptotic cell death 
(Kumagai et al., 2003). 
 Lipopolysaccharides (LPS), a component of Gram-
negative bacterial cell wall has been reported to initiate 
neuroinflamation by activating the microglia cells and induce 
changes within the hippocampus and entorhinal cortex. 
(Dobrovolskaia and Vogel, 2002, Min et al., 2009). This 
peripheral inflammatory milieu can be relayed to the central 
nervous system through vagus nerve activation, circumventricular 
organs and brain endothelial cell activation (Ching et al., 2007, 
Akrout et al., 2009). The systemic administration of LPS activates 
microglia leading to neurodegeneration, suppression of 
neurogenesis and impairment of cognitive behavior in mice and 
rats (Qin et al., 2007, Lee et al., 2008; Okun et al., 2010). LPS 
have also been shown to damage neurons by causing oxidative 
stress through depletion in the levels of antioxidant enzymes 
which foster free radical generation by increasing brain MDA and 
reduction  in GSH content (Kheir-Eldin et al., 2001; Sebai et al., 
2009).  Therefore, use of antioxidants has been recognized as an 
effective method in minimizing pathological and toxic effects 
associated with oxidative stress caused by neurotoxic agents. 
Numerous ethnomedicinal plants have been used to treat several 
cognitive disorders including Alzheimer's disease. They act as 
excellent antioxidants, anti-inflammatory mediators, cholinesterase 
and β-secretase inhibitors. In addition, these natural compounds 
also prevent the accumulation of amyloid beta and its fibril 
formation (Khan et al., 2012). Besides acting as core-molecules, 
these natural compounds act as a template for the production and 
synthesis of several drug leads with improved pharmacokinetic 
potentials and greater efficacies. Hence, medicinal herbs that have 
interesting pharmacological effects with noticeable anti-
Alzheimer's disease potential deserves increased attention for 
further development to drug entities.  
 Ethnobotanical survey of plants locally used for memory 
enhancement among the Yoruba people of  Southwestern Nigeria 
indicated that of all the species used, three different plants Bacopa  
floribunda Scoparia dulcis belonging to the family 
Scrophulariaceae and Cordia millenii family Bignoniaceae are 
more frequently used. A literature search has revealed that 
numerous traditional medicinal plants have been used to treat 
several cognitive disorders including Alzheimer's disease. They act 
as excellent antioxidants, anti-inflammatory mediators, 
cholinesterase and β-secretase inhibitors. (Oken et al., 1995, 
Skolnick, 1997; Durairajan et al., 2008).  Although, Bacopa  
floribunda,  Scoparia dulcis and Cordia millenii plants are 
currently being used for memory enhancement and 
management/treatment of neurodegenerative diseases in folk-
medicine, there are limited scientific studies on their 
neuroprotective effect. Hence, the current study sought to 
investigate their neuroprotective effect against LPS-induced 
neuroinflammation in mice. In this context, we assessed the 
efficacy of the three plants in ameliorating the inflammation of the 
neuronal cells through histo-morphological analysis and 
preventing oxidative stress through biomarkers of antioxidant 
status. 
 
MATERIALS AND METHODS 
 
Sample collection and preparation of plant extracts 
Fresh samples of the plant materials (Bacopa floribunda, 
Scoparia dulcis and Cordia millenni) were obtained from a 
farmland at Ado-Ekiti metropolis, Nigeria. Authentication of the 
plants was carried out at the Department of Botany, Ekiti State 
University, Ado-Ekiti, Nigeria. The samples were air dried at 
ambient room temperature and made into powdery form using a 
grinder. The plant extracts were prepared by refluxing (50-60 
o
C) 
10 g of each sample with 100 ml 80% ethanol for 30 min. This 
was repeated thrice with fresh solvent each time, followed by 
filtration using muslin cloth and the filtrate was lyophilized to 
dryness. The lyophilized samples were collected and stored at -20 
0
C until use for subsequent analysis Kumar et al., 2012. 
 
Animals 
Forty nine (49) BALB/c male mice weighing between 
25-30 g were obtained from the central animal house, College of 
Medicine, Afe Babalola University Ado Ekiti, Nigeria. They were 
caged, maintained at room temperature under standard 12–12 h 
light–dark cycle and allowed free access to water and 
commercially produced diet ad libitum. Treatment protocols were 
in accordance with the ethical requirements of the Animal Care 
and Use Research Ethics Committee of the University of Ibadan, 
Nigeria with approval number (UI-ACUREC/16/0043). 
 
Experimental Protocol 
In this study, 49 BALB/c male mice were divided into 
seven groups of 7 animals each (n=7). All animals except for 
group I (control) received saline (vehicle), were injected 
intraperitoneally (ip) with 250 μg/kg of Lipopolysaccharide (LPS). 
For all experiments, LPS (Escherichia coli, serotype 055:B5, 
Sigma, St. Louis, MO, USA) induced an inflammatory response 
and was injected once (ip) after oral pre-treatment with plant 
extracts and control drugs for 7 days.  Group II received LPS 
(Control) only, group III received LPS + Sulindac Sulfide (SS, 4 
mg/kg) an anti-inflamatory agent, group IV received LPS + 
Donepezil (DPZ, 1 mg/kg) a standard drug for the treatment of 
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AD), group V  LPS + Scoparia dulcis (SD) at 200 mg/kg, Group 
VI received Bacopa floribunda (BF) at 200 mg/kg, group VII  
received Vehicle + LPS Cordia millenii (CM) at 200 mg/kg.  The 
choice of this dose of 200 mg/kg of plant extracts was made on the 
basis of our preliminary study that used the same concentration 
and obtained beneficial result with no toxic effect on the brain of 
mice. All injections were administered 4hrs prior to sacrifice of the 
animals. This allows enough time for the development of neuro-
inflammation (most notably in Hippocampus) at this dose and 
similar doses of intraperitoneal LPS (Vernetder et al., 1998). 
Except for LPS injected intraperitoneally, all the drugs and 
extracts were reconstituted in the vehicle (normal saline) and were 
administered orally. The dosage for the administration was carried 
out using 1 ml per 1 kg animal body weight. 
 
Animal Sacrifice 
After the completion of experiment, mice were 
decapitated under mild diethyl ether anesthesia and the cerebral 
tissue (whole-brain) was rapidly dissected and placed on ice and 
weighed. 
 
Preparation of brain homogenates 
The brain tissue (n=5) was subsequently homogenized in 
cold 0.1 M phosphate buffer, pH 8.0), with about 10-up-and-down 
strokes at approximately 1200 rev/min in a Teflon-glass 
homogenizer. The homogenate was centrifuged for 10 min at 3000 
rpm to yield a pellet that was discarded and a low-speed 
supernatant was kept for antioxidant assay. Antioxidant potential 
was determined in both the brain tissue and serum by measuring 
activities of superoxide dismutase (SOD), catalase (CAT), 
Malondialdehyde (MDA), and reduced glutathione (GSH) in 
whole-brain homogenates according to the method of Ohkawa et 
al. (1979). 
 
Histology procedure 
Brain tissue (n=2) from each group were transferred to 
10% formal saline for fixation. After which they processed for 
histological staining of the hippocampus using Hematoxylin and 
Eosin (H&E) stain. 
 
RESULTS 
 
Effect of LPS-Induced Neuronal Damage on Some Oxidative 
Stress Biomarkers 
Figure 1 and Fig. 2 shows the malondialdehyde (MDA) 
level in all the experimental groups in the brain homogenates and 
serum respectively. There was significant increase (p < 0.01) in the 
level of MDA both in the brain tissue and blood serum of the 
untreated LPS-induced mice when compared with the vehicle 
group. In addition, there was also significant difference in the 
treated groups SS, DPZ and BF which were significantly reduced 
(p < 0.05) when compared with untreated LPS-induced mice. 
However, CM showed a decrease (non-significant) in MDA 
concentration of the brain homogenate but a better activity was 
observed in the serum. 
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Fig. 1: Mice Brain MDA Status; Effect of Orally Administered Three 
Medicinal Plants for 7 Days.  The MDA levels in whole brain tissue (Fig.1). 
Values were expressed as mean ± S.E.M values (n = 5/group) and analyzed by 
one-way ANOVA and multiple comparisons were performed by Tukey HSD 
test. A criterion of significance was accepted and marked as P < 0.05 (#) and 
0.01 (** or ##). The mark of * is LPS group versus Vehicle group and the mark 
of # is each treatment group versus LPS group ns; not significant. 
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Fig. 2: Mice Serum MDA Status; Effect of Orally Administered Three 
Medicinal Plants for 7 Days. The MDA levels in the blood serum (Fig. 2). 
Values were expressed as mean ± S.E.M values (n = 5/group) and analyzed by 
one-way ANOVA and multiple comparisons were performed by Tukey HSD 
test. A criterion of significance was accepted and marked as P < 0.05 (#) and 
0.01 (** or ##). The mark of * is LPS group versus Vehicle group and the mark 
of #  is each treatment group versus LPS group ns; not significant. 
 
Tables 1 and 2 showed the biochemical parameters 
(SOD, CAT and GSH) in the brain homogenates and serum 
respectively. In the brain homogenates, there was significant (p < 
0.05) increase in the level of catalase (CAT) enzyme activity in the 
treated group and the control drug groups (SS and DPZ) when 
compared with the untreated LPS-induced group. The group 
treated with BF and CM extract showed better increase in the 
serum, whereas, only the CM treated group followed the same 
trend in the brain homogenate. The glutathione reductase (GSH) 
contents in all the experimental groups of mice showed significant 
increase (p<0.05) when compared with the untreated LPS-induced 
group especially in the serum. There was no significant difference 
in the superoxide dismutase (SOD) activity in all experimental 
groups both in the brain homogenates and serum. 
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Histopathological Analysis of Hippocampus [Cornus 
Ammonis-1 (Ca1)] of LPS-Induced Neuronal Damage in Mice 
Histological analyses of hippocampus in the control             
and experimental groups of mice were   shown  in  Figure  (3A-G). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histological sections were imaged at a magnification of 400. 
Control animals showed normal histological architecture in the 
hippocampus showing a distinct region of the hippocampus 
composed of packed cappilliary cells (CAP), glia cells (GC) and 
Table 1: Effect of Oral Administration of Three Medicinal Plants for 7 days in Brain Antioxidant Status of Mice Treated with LPS. 
Treatment SOD (U/mg protein) CAT (nmol/mg protein) 
GSH (nmol/min 
/mg protein) 
Vehicle 97.86 ± 0.71 1287.57 ± 110.6 223.9 ± 0.23 
Vehicle+LPS (250g/kg 96.43 ± 0.92 911.84 ± 96.4* 220.1 ± 1.21* 
Vehicle +LPS+SS 96.79 ± 0.68 925.20 ± 28.8*# 222.88 ± 0.34*# 
Vehicle+LPS+DPZ 97.14 ± 1.01 979.85 ± 30.5*# 223.57 ± 0.29*# 
Vehicle +LPS+SD 96.07 ±0.35 1363.51± 157.1# 222.29± 1.17*# 
Vehicle+LPS+BF 95.54 ±0.61 1029.26 ± 63.7*# 224.63± 0.32*# 
Vehicle+LPS+CM 97.49 ± 0.36 929.69 ± 63.7* 221.14± 0.44* 
The mice brain biochemical parameters are expressed as mean ± S.E.M values (n = 5/group).  
Values within each column with different superscript letters (* and #) are significantly different (p<0.05) *when compared with Vehicle group and #when 
compared with the LPS group determined using One –way ANOVA.  
 
Table 2: Effect of Oral Administration of Three Medicinal Plants for 7 Days In Serum Antioxidant Status of Mice Treated with LPS.  
Treatment SOD (U/mg protein) 
CAT 
(nmol/mg protein) 
GSH  (nmol/min 
/mg protein) 
Vehicle 98.28 ± 0.29 1399.40±47.45 227.94 ± 0.92 
Vehicle+LPS (250g/kg 97.5 ± 0.68 945.32± 35.97* 223.57± 0.82* 
Vehicle +LPS+SS 98.29 ± 0.29 2007.36± 64.92*# 223.39 ± 0.86* 
Vehicle+LPS+DPZ 98.57 ± 0.00 511.17 ± 43.02 227.71 ± 2.42* 
Vehicle +LPS+SD 98.57 ± 0.00 1190.51± 29.64.1*# 226.84± 0.76* 
Vehicle+LPS+BF 97.62 ±0.48 390.77 ± 39.28 232.01± 0.7*# 
Vehicle+LPS+CM 97.85 ± 0.71 825.79± 26.56 234.18± 1.22*# 
The mice brain biochemical parameters are expressed as mean ± S.E.M values (n = 5/group).  
Values within each column with different superscript letters (* and #) are significantly different (p<0.05)  *; when compared with Vehicle group  and #; when 
compared with the LPS group determined using One –way ANOVA 
 
 
A: VehicleX400 µm Photomicrograph shows section 
of the hippocampus showing the cappilliary (CAP), 
glia cell (GC) and dentate gyrus (DG) composed 
tightly packed granule cell layer(Arrow). 
 
B: LPSx400 µm: Photomicrograph shows section of 
the hippocampus with mild degenerative changes 
within the CA strata (arrow). 
 
C: LPS+SS x400 µm Section shows hippocampus 
tissues composed of capillary (Arrow), glia cell 
(GC), nerve Cell (NC), nueropil (NP). Their histo-
cytoarchitecture appears unremarkable. 
 
 
D: LPS+ DPZ x400 µm Photomicrograph shows the 
hippocampus tissue showing the moderate 
degenerative changes (pyknosis) within the neuron 
of the CA region. Arrow shows the blood vessel. 
 
 
E: LPS + BF x400 µm: Appear as in Section 
control. 
 
F: LPS + SD x400 µm: Section shows mild fat 
deposition within the CA strata.  
 
G:  LPS + CM   X400 µm 
 
 
 
 
KEY: SS= Sulindac Sulfide, LPS= 
Lipopolysaccharide, DPZ= Donepezil , SD= 
Scoparia dulcis, BF= Bacopa floribunda, and CM= 
Cordia millenii  
 
 
 
Fig. 3A-G: Histology Showing the Haematoxylin and Eosin Staining of the Mouse Hippocampus. 
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dentate gyrus (DG), (Fig. 3A). Neuronal cells in LPS-induced 
when injected intraperitoneally with 250 µg/kg LPS, 4 hours 
before mice were sacrificed was characterized by retraction of cell 
bodies resulting in the formation of a clear space around the 
degenerating neurons accompanied with pyknotic and condensed 
nuclear morphology within the CA strata of the hippocampus. 
(Fig. 3B). The Sulindac Sulfide (SS), an antiinflamatory agent, 
treated mice exhibited significant reduced morphologic 
abnormalities, a characteristic of protected cellular morphology, 
than that of anticholinergic standard drug Donepezil (DPZ) in the  
hippocampus tissue showing the moderate degenerative changes 
(pyknosis) within the neuron of the CA region. Arrow shows the 
blood vessel, (Fig. 3C and Fig. 3D). Among the three tested plants, 
Scoparia dulcis (SD) treated group showed an appreciable reduced 
morphologic abnormalities but leaving some traces of fat 
deposition within the CA strata the reason which could not yet be 
explained when compared to the other two sample Bacopa 
floribunda (BF) and Cordia millenii (CM) did not exhibit 
appreciable changes in the hippocampus (Fig. 3E, Fig. 3F and Fig. 
3G). 
 
DISCUSSION 
 
Numerous factors have been reported to improve 
memory impairment (Tong et al., 2009), and brain antioxidant 
status (Nicolakakis et al., 2008). The brain and nervous system are 
thought to be particularly vulnerable to oxidative stress due to their 
limited antioxidant capacity, it consumes 20 percent of the 
metabolic oxygen, neurons cannot synthesize glutathione and 
contains more of polyunsaturated fatty acids (Marksberry and 
Lovell, 2007; Oboh and Rocha, 2007). Evidence shows that 
reactive oxygen species (ROS) mediated oxidative stress triggers 
apoptotic signal and subsequent neuronal death (Wang et al., 
2013). These ROS was reported to be continuously produced in 
aerobic organisms as a byproduct of metabolism and during 
phagocytosis by macrophages including microglia. An imbalance 
in the redox homeostasis caused by ROS generation leads to 
deficit in cellular antioxidant defense system which in turn renders 
the lipids, protein and DNA vulnerable to free radical attack 
culminating in oxidative stress that underlies multitudinous 
pathologies including neurodegeneration (Aruoma, 1998; 
Halliwell and Gutteridge, 1999). ROS can directly attack the 
polyunsaturated fatty acids of the cell membranes and induce lipid 
peroxidation. Malondialdehyde (MDA) is the end-product of lipid 
peroxidation, which is a process where ROS degrade 
polyunsaturated fatty acids. This compound is a reactive aldehyde 
and is one of the many reactive electrophile species that cause 
toxic stress in cells and form advanced glycation end-products. 
The production of this aldehyde is used as a biomarker to measure 
the level of oxidative stress in an organism (Murray et al., 2000). 
The present study has revealed that the administration of 
lipopolysaccharide (LPS) induced lipid peroxidation in mice brain 
and serum tested when compared with the control without LPS. 
This is in agreement with previous studies that have shown LPS to 
be a stimulator of lipid peroxidation (Yoshikawa et al., 1994; Stuss 
et al., 2010; Sewerynek et al., 2011). LPS induces the synthesis of 
nitric oxide by catalyzing L-arginine oxidation to citrulline and to 
the toxic form of nitric oxide (NO•) (Jiang-Shieh et al., 2005). The 
reaction of nitric oxide with superoxide anion (O2•–) leads to the 
formation of highly toxic peroxynitrite anion (ONOO–) that can 
initiate lipid peroxidation of neuronal cell membranes (Jiang-Shieh 
et al., 2005). However, our results clearly show that all the plant 
extracts tested decreased lipid peroxidation, previously induced by 
LPS, in the brain and serum examined tissue (Fig. 1 and. Fig. 2). 
Additionally, sample BF exerted the strongest inhibitory effects. 
The inhibitory effect of the plant samples could be due to their 
potent antioxidant activities as evidenced by the restoration of 
enzymatic antioxidant activity (CAT) and non-enzymatic 
antioxidant (GSH) in LPS-induced oxidative neuronal damage in 
mice (Tables 1 and 2). 
 The activity of SOD is a sensitive index in oxidative 
damage as it scavenges the superoxide anion to form hydrogen 
peroxide leading to diminish the toxic effects in the brain (Khan et 
al., 2012). However, there was no significance difference in the 
SOD activities both in the blood serum and the brain homogenate 
of this study. The reason for this could not be categorically stated, 
but may be reasoned out that SOD being the first line of defense 
against ROS may remain unnoticed. The next line of antioxidant 
defense is the catalase (CAT) enzyme which is an enzymatic 
antioxidant widely distributed in all animal tissues that decompose 
hydrogen peroxide and protect the tissue from highly reactive 
hydroxyl radicals (Khan et al., 2012). The present work has 
revealed that the administration of the three plant extracts showed 
their potentials as exogenous antioxidants. Although the level of 
action of the CM sample seemed not to be well pronounced, 
however, it exhibited some level of protection against free radicals 
in both the blood serum and the brain. 
 Reduced glutathione (GSH) and glutathione reductase is 
thought to be the fundamental antioxidant enzymes, for they are 
closely related to the direct elimination of reactive oxygen species 
(ROS). Therefore, the reduction in the activity of these enzymes 
may result in a number of deleterious effects due to the 
accumulation of superoxide radicals and hydrogen peroxide, 
linked with neurodegenerative diseases (Fang et al., 2000). The 
brain and nervous system are thought to be particularly vulnerable 
to oxidative stress due to their limited antioxidant capacity and 
reduced glutathione level (Marksberry and Lovell 2007; Oboh and 
Rocha 2007). The administration of LPS caused a reduction in the 
GSH level, however, pre-treatment with all the plant extracts were 
able to spare the endogenous antioxidant level in this case, GSH 
when compared with the control without LPS. This is probable an 
indication that the plants contain important antioxidant mechanism 
of action that can fight against the free radicals produced from 
LPS administration.  
Histological study showed a neurodegeneration 
evidenced by the neuronal loss observed in the LPS treated group. 
To determine whether animal models of neurodegenerative 
disorder such as AD recapitulate degeneration of specific neuronal 
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types as seen in human patients, it is first necessary to evaluate 
whether neurodegeneration occurs in animal models.  It is 
sometimes important to establish probably at which age and in 
which part of the brain neurodegeneration frank loss of neurons 
begin and how quickly neurodegeneration progresses. Histological 
analysis revealed that LPS-induced mice exhibited condensed and 
pyknotic nuclear morphology in the hippocampus, a characteristic 
of severe degenerative changes. This was further corroborated with 
the memory impairment observed in the spatial memory function 
of a behavioral study carried out (data not shown). These abnormal 
histological architecture could be attributed to oxidative stress 
induced neuronal apoptosis by LPS. Protected cellular morphology 
discernible among the treated group animals might be due to their 
anti apoptotic effect as cell death modes are classified as necrosis, 
apoptosis, or autophagic based on the cell’s morphological 
features (Lee et al., 2008), although the mechanism and process 
underlying cell death are complex and vary among different 
diseases. Also, neurodegeneration in AD has been reported to be 
usually accompanied by a chronic inflammatory response 
including glia cells and complement activation and the release of 
proinflamatory cytokines from glial sells (Marco et al., 2013). 
 
CONCLUSION 
 
Based on the present study, all the plant extracts tested 
prevented oxidative damage induced by administration of LPS 
induced neuroinflammation in mice. This activity could be 
attributed to their antioxidant potential as evidenced from their 
inhibitory effect on MDA and increased CAT activity and GSH. 
Nevertheless, other possible mechanisms of action against 
neuronal damage need to be assessed to further justify their use 
traditionally in the treatment/management of neurodegenerative 
diseases.   
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